SLC12A5 and epilepsy: Consequently, strategies aimed at counteracting the observed decrease in KCC2 levels in our drug resistance model, through the implementation of pharmacological or genetic interventions [47,48,49], hold considerable potential for the restoration of neuronal excitability homeostasis in drug-resistant epilepsy.